knowledge -WSS

knowledge

author：focus 2025-09-29 14:00:28 - browse：1

Jamy Ard (left) and Robert Lustig (right) on the 2023 STAT Breakthrough Summit stage -- coverage from STAT — Obesity experts Jamy Ard (left) and Robert Lustig speak at a panel during the 2023 STAT Breakthrough Summit. Sarah Gonzalez for STAT

Amid rising demand for drugs like Wegovy, Ozempic, and Mounjaro that can lead to significant weight loss, some obesity experts are concerned about the drugs’ costs — both to patients’ finances and to their health.

Speaking at a panel on new obesity treatments at the STAT Breakthrough Summit in San Francisco on Thursday, one expert cited a large clinical trial for Wegovy that showed that about 40% of the weight participants lost was lean mass. Side effects like nausea, vomiting, and a possible link to rare cases of pancreatitis also still plague this newest class of drugs, which imitate the effects of a hormone called glucagon-like peptide 1 (GLP) that helps people feel full.

“That’s what starvation does. You lose equal amounts of muscle and fat,” said Robert Lustig, emeritus professor of pediatrics at the University of California, San Francisco. “If you’re a person 60 years old or over and you’re losing muscle, your risk of dying just went up exponentially. So we may be … robbing Peter to pay Paul.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Orchard's therapy for neuron disease in children wins FDA approval

WSS

Neuroscience’s long legacy of racism

After a decade, new Gardasil ad campaign gets it (mostly) right

The stock market has soared this year, but will it last? Experts weigh in

Stop the failed accountable care organization experiment

Telehealth startups are trying to fill the menopause care vacuum

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

entertainment

knowledge

explore

In age of alternative facts, a scholarly course on calling out crap

Colonoscopy prep: Liquid

Cancer drug shortages should be causing more outrage

There’s a way to spot data fakery. All journals should be using it

Duchenne breakthrough therapy leaves behind pioneering families

Health AI adoption puts security, privacy startups on investors' radar

New air purifier tech could be key to improving indoor air quality

Delta passengers in Vegas fall sick while waiting on flight in triple

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Sanders wants to replace patents with prizes for drug inventions

hotspot

How a Boston hospital is priming medical residents to use GPT

AstraZeneca to buy developer of next

Baby aspirin cuts fat buildup in liver disease patients, in small study

Orchard's therapy for neuron disease in children wins FDA approval

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

Scientists grapple with ethics of stem cell research

explore

hotspot

explore

focus